Abstract

BackgroundMolecular characterization of individual cancer patients is important because cancer is a complex and heterogeneous disease with many possible genetic and environmental causes. Many studies have been conducted to identify diagnostic or prognostic gene signatures for cancer from gene expression profiles. However, some gene signatures may fail to serve as diagnostic or prognostic biomarkers and gene signatures may not be found in gene expression profiles.MethodsIn this study, we developed a general method for constructing patient-specific gene correlation networks and for identifying prognostic gene pairs from the networks. A patient-specific gene correlation network was constructed by comparing a reference gene correlation network from normal samples to a network perturbed by a single patient sample. The main difference of our method from previous ones includes (1) it is focused on finding prognostic gene pairs rather than prognostic genes and (2) it can identify prognostic gene pairs from gene expression profiles even when no significant prognostic genes exist.ResultsEvaluation of our method with extensive data sets of three cancer types (breast invasive carcinoma, colon adenocarcinoma, and lung adenocarcinoma) showed that our approach is general and that gene pairs can serve as more reliable prognostic signatures for cancer than genes.ConclusionsOur study revealed that prognosis of individual cancer patients is associated with the existence of prognostic gene pairs in the patient-specific network and the size of a subnetwork of the prognostic gene pairs in the patient-specific network. Although preliminary, our approach will be useful for finding gene pairs to predict survival time of patients and to tailor treatments to individual characteristics. The program for dynamically constructing patient-specific gene networks and for finding prognostic gene pairs is available at http://bclab.inha.ac.kr/pancancer.

Highlights

  • Molecular characterization of individual cancer patients is important because cancer is a complex and heterogeneous disease with many possible genetic and environmental causes

  • Group 1 is a set of samples with a gene pair that show a relatively large change in Pearson correlation coefficient (PCC) from normal samples and group 2 is a set of the remaining samples

  • One gene (TFAP2C) from noncancer signatures is included in our prognostic gene pair LINC01234_TFAP2C, and the remaining 146 prognostic gene pairs contain no noncancer signatures. These results indicate that the prognostic gene pairs found by our method in breast cancer are not associated with proliferation genes and that the prognostic gene pairs are not associated with noncancer signatures, either

Read more

Summary

Introduction

Molecular characterization of individual cancer patients is important because cancer is a complex and heterogeneous disease with many possible genetic and environmental causes. Many studies have been conducted to identify diagnostic or prognostic gene signatures for cancer from gene expression profiles. Some gene signatures may fail to serve as diagnostic or prognostic biomarkers and gene signatures may not be found in gene expression profiles. Cancer is a very heterogeneous and complex disease with many possible genetic and environmental causes. Many targeted therapies are effective only for patients with specific genetic alterations (known as driver mutations) that help cancer cells form and grow [1, 2]. Several methods have been developed for exploring gene expression characteristics [4,5,6,7,8] or for constructing gene networks of several types

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call